Virus News and Research

Latest Virus News and Research

WHO requests $675 million for coronavirus battle

The Wuhan coronavirus is vastly spreading in China and other countries across the globe. Since it was declared to be a global health emergency by the World Health Organization (WHO), many countries have imposed travel bans and on the ground response to contain the virus and prevent further spread.

6 Feb 2020

Coronavirus update: Crucial information about transmission, diagnosis, treatment

The novel coronavirus (2019-nCoV) that has spread from China to more than 25 countries, is more difficult to contain than previously thought. The death toll from the infection soars past 565, with more than 28,256 confirmed cases. Scientists from around the globe are racing to determine the mode of transmission and how the virus spreads at such a rapid pace.

6 Feb 2020

Experts advise against using steroids for treatment of coronavirus

Steroids should be avoided in the treatment of the current novel coronavirus, experts have advised.

6 Feb 2020

2019-nCoV: Infectious virus can be isolated from nose, throat swabs of patients with mild symptoms

Laboratory testing by Charité - Universitätsmedizin Berlin, the Bundeswehr Institute of Microbiology and Munich Clinic Schwabing has revealed that infectious virus can be isolated from nose and throat swabs even where these have been obtained from patients with mild symptoms.

6 Feb 2020

Novel tool monitors influenza A virus mutations in real time

A Rutgers-led team has developed a tool to monitor influenza A virus mutations in real time, which could help virologists learn how to stop viruses from replicating.

6 Feb 2020

Few tips on how to talk to your child about coronavirus

Disease outbreaks are scary, especially when it's a new virus that's infecting people on a large scale.

6 Feb 2020

MR Solutions installs 3T PET-MR system at Western University’s ImPaKT facility

MR Solutions has installed a 3T PET-MR preclinical imaging system at Western University’s one of a kind ImPaKT Laboratory in Ontario.

From MR Solutions 5 Feb 2020

GSMA: Updated statement on novel coronavirus

The GSMA continues to monitor and assess the potential impact of the Coronavirus on its MWC20 events held annually in Barcelona, Shanghai and Los Angeles and as well as the Mobile 360 Series of regional conferences.

5 Feb 2020

First comprehensive survey of viruses found within different cancers

Researchers from the University of East Anglia have helped to carry out the first comprehensive survey of viruses found within different types of cancer.

5 Feb 2020

Key changes to Adult and Child Immunization schedule for 2020

The new Childhood and Adolescent Immunization Schedule and the Adult Immunization Schedule for 2020 are out, just released by the Advisory Committee on Immunization Practices (ACIP). This is an annual event following its yearly revision.

5 Feb 2020

Coronavirus: CT scans of chest could help in early diagnosis

Researchers have managed to radiologically view the novel coronavirus infected individuals, and this could be a step towards early detection of this virus and diagnosis of those infected by it. The study titled, “CT Imaging Features of 2019 Novel Coronavirus (2019-nCoV),” was published this week in the journal Radiology.

5 Feb 2020

Coronavirus can’t spread if the patient doesn’t have symptoms, report says

Key information that has been spreading about the mode of transmission of the deadly Wuhan coronavirus or 2019-nCoV is wrong, a new report says.

5 Feb 2020

Titanium nanoparticles found in coal smog and ash can cause lung damage in mice

Virginia Tech scientists have discovered that incredibly small particles of an unusual and highly toxic titanium oxide found in coal smog and ash can cause lung damage in mice after a single exposure, with long-term damage occurring in just six weeks.

5 Feb 2020

Epiglottitis linked to teenager's use of e-cigarettes

A teenage girl with no hint of prior asthma or respiratory illness began to feel hoarseness in her throat and a feeling that she needed to clear her throat frequently.

5 Feb 2020

Spread of coronavirus extends far beyond Wuhan and other quarantined cities

Infectious disease researchers at The University of Texas at Austin and other institutions in Hong Kong, mainland China and France have concluded there is a high probability that the deadly Wuhan coronavirus spread beyond Wuhan and other quarantined cities before Chinese officials were able to put a quarantine in place.

5 Feb 2020

Portable device paves way for better detection of foodborne illness

Foodborne illness hits about one in six people in the United States every year. The Centers for Disease Control and Prevention estimates that 48 million people in the U.S. get sick due to one or more of 31 recognized pathogens, including E. coli O157:H7, a particularly harsh strain of E. coli.

4 Feb 2020

Hendra antibody trial shows promise in a world-first human clinical trial

The Hendra virus is a potent pathogen transmitted to humans from animals that cause a severe and often fatal illness in both infected horses and humans. Originating from fruit bats, the virus caused an outbreak in Australia in 1994.

4 Feb 2020

Unveiling the structure of the influenza virus

The flu season is coming, and the frigid temperatures make it worse. The influenza B virus is the causative agent of the common flu, but over the past years, it has become more potent in causing disease. Now, a team of MIT scientists has found and unveiled the structure of the virus, particularly the key influenza protein, in the hopes to develop new drugs to combat influenza.

4 Feb 2020

Promising HIV vaccine fails in a large-scale clinical trial

The human immune deficiency virus (HIV) is an infectious disease that can lead to immunosuppression called acquired immunodeficiency syndrome (AIDS). For decades, scientists race to discover a vaccine that can help prevent the spread of the virus. The latest trial testing a new experimental vaccine in South Africa end in disappointment after deeming ineffective in preventing infection.

4 Feb 2020

FDA-approved OIT product marks major milestone in management of peanut allergies

In February 2020, the U.S. Food and Drug Administration (FDA) approved Palforzia, the first peanut powder product designed to help reduce the risk of severe peanut-induced allergic reactions through desensitization over time.

4 Feb 2020